An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.
Jpn J Ophthalmol
; 65(6): 843-848, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-34586526
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uveitis
/
Behcet Syndrome
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Jpn J Ophthalmol
Year:
2021
Document type:
Article
Affiliation country:
Japan